A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)
Not Applicable
Not yet recruiting
- Conditions
- Coronary heart disease
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Meeting the diagnostic criteria for coronary heart disease in Western medicine; (2) aged 18-85 years; and (3) signing an informed consent form.
Exclusion Criteria
(1) Patients with severe primary diseases such as combined hepatic and renal insufficiency, hematopoietic system abnormalities, and neurological diseases; (2) Pregnant or lactating women.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie qi and blood circulation promotion in coronary heart disease treatment?
How does promoting qi and blood circulation compare to standard-of-care therapies for coronary artery disease?
Are there specific biomarkers that predict response to qi and blood circulation therapies in ischemic heart disease?
What adverse events are associated with traditional Chinese medicine approaches for coronary heart disease?
What combination therapies are being explored alongside qi promotion for coronary heart disease management?